{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3544, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/8", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-8", "loopMatches": [ { "to": 9, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9bd8f891-6c1f-4017-910c-a4db24384913", "evidence": "The deck presents Eos Z3 Path to Profitability", "position": 0, "objective": "Highlighting the importance of Eos Z3", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "e8b3c0f4-4e2a-4e4b-bd18-7d6fdc0b0fd2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents Eos Z3 Launch Update and Commercial Pipeline & Orders Backlog", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a funnel-like progression from lead generation to backlog.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/9", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-9", "loopMatches": [ { "to": 9, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9bd8f891-6c1f-4017-910c-a4db24384913", "evidence": "The deck presents Eos Z3 Path to Profitability", "position": 0, "objective": "Highlighting the importance of Eos Z3", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "e8b3c0f4-4e2a-4e4b-bd18-7d6fdc0b0fd2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents Eos Z3 Launch Update and Commercial Pipeline & Orders Backlog", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "customer_journey", "function": "present_framework", "notes": "The slide uses a process flow framework to explain revenue recognition and cash collection timing.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/10", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-10", "loopMatches": [ { "to": 12, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2a14e98c-9e70-4ceb-b2de-9a0588997647", "evidence": "The deck presents Financial Results", "position": 1, "objective": "Showcasing financial progress", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 13, "from": 10, "beatId": "84ea2a7d-0e87-4442-8975-99db7e99b3d3", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with Financial Results and Progress Against 2023 Objectives", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/11", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-11", "loopMatches": [ { "to": 12, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2a14e98c-9e70-4ceb-b2de-9a0588997647", "evidence": "The deck presents Financial Results", "position": 1, "objective": "Showcasing financial progress", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 13, "from": 10, "beatId": "84ea2a7d-0e87-4442-8975-99db7e99b3d3", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with Financial Results and Progress Against 2023 Objectives", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a waterfall-style comparison for Revenue and COGS to emphasize year-over-year changes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/12", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-12", "loopMatches": [ { "to": 12, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2a14e98c-9e70-4ceb-b2de-9a0588997647", "evidence": "The deck presents Financial Results", "position": 1, "objective": "Showcasing financial progress", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 13, "from": 10, "beatId": "84ea2a7d-0e87-4442-8975-99db7e99b3d3", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with Financial Results and Progress Against 2023 Objectives", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a structured list format to present three distinct performance categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/13", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 10, "beatId": "84ea2a7d-0e87-4442-8975-99db7e99b3d3", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with Financial Results and Progress Against 2023 Objectives", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/z6N6wcbO0Y60jmQeY6HKZ5bcVfUEz-aiPcXM67pWyDo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMWU2NmEyMWE1ZjcyYWMxMjJkZDhmNzlkNjNiNDBkOS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/1", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/ED3CvgvlWSJQ6fw_LCcJ5dNpcZVVyNUV8R6KPxYSqAU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMWU2NmEyMWE1ZjcyYWMxMjJkZDhmNzlkNjNiNDBkOS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/eOLjVKaYApemjqyZ94mQO4laGCcfyMbm54QzxzbfPnE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMWU2NmEyMWE1ZjcyYWMxMjJkZDhmNzlkNjNiNDBkOS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/sPwa7qurWtntiejpTY_5kWfdKDspdm6aMtspuX6PL3w/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMWU2NmEyMWE1ZjcyYWMxMjJkZDhmNzlkNjNiNDBkOS9wMDAxLnBuZw" }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/2", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a hub-and-spoke diagram to centralize the company brand around key investment pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/3", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization for clinical trial stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/4", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": "This is a section divider or introductory slide for the product solution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/5", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "e5014b0a-2ea1-4c1d-aa62-8b23051676e0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The deck presents Equillium's solution, including itolizumab and EQ101", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "traction", "function": "show_traction", "notes": "Includes footnote regarding currency exchange rate for the option exercise payment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/6", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "e5014b0a-2ea1-4c1d-aa62-8b23051676e0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The deck presents Equillium's solution, including itolizumab and EQ101", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "roadmap", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/7", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "e5014b0a-2ea1-4c1d-aa62-8b23051676e0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The deck presents Equillium's solution, including itolizumab and EQ101", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/8", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "e5014b0a-2ea1-4c1d-aa62-8b23051676e0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The deck presents Equillium's solution, including itolizumab and EQ101", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "context", "function": "establish_context", "notes": "Includes a diagram illustrating cytokine-receptor binding and downstream signaling.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/9", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 9, "beatId": "b93c3a06-c831-43d6-b95d-b6d4951d54b8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The deck presents a clear problem statement around the challenges in targeting cytokine signaling", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a visual comparison to frame the problem of 'too narrow' vs 'too broad' inhibition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/10", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 9, "beatId": "b93c3a06-c831-43d6-b95d-b6d4951d54b8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The deck presents a clear problem statement around the challenges in targeting cytokine signaling", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "solution", "function": "present_solution", "notes": "The diagram uses a hub-and-spoke model to show how various scientific disciplines feed into the central 'Drug Products' core.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/11", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 9, "beatId": "b93c3a06-c831-43d6-b95d-b6d4951d54b8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The deck presents a clear problem statement around the challenges in targeting cytokine signaling", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "solution", "function": "present_solution", "notes": "The slide highlights the structural commonality of the γC receptor across multiple cytokines, positioning it as a therapeutic target.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/12", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "solution", "function": "present_solution", "notes": "The slide illustrates a structural biology approach to drug design, focusing on helix-receptor interactions and sequence engineering.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/13", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a combination of biological process diagrams and a bar chart to demonstrate selective inhibition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/14", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide uses a visual comparison framework to illustrate the mechanism of action and therapeutic benefits.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/15", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "transition", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/16", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a structured layout to compare four distinct market segments (Cutaneous T cell Lymphoma, Alopecia Areata, Vitiligo, Atopic Dermatitis) with specific patient counts and clinical status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/17", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 17, "beatId": "1b331d6c-cf93-440f-9b58-a2062c2128d5", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The deck presents market sizing information for EQ101", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a four-column structure to explain the target, the molecule type, preclinical results, and clinical results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/18", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 17, "beatId": "1b331d6c-cf93-440f-9b58-a2062c2128d5", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The deck presents market sizing information for EQ101", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "comparison_table", "function": "compare_peers", "notes": "Western blot data visualization comparing pathway activation (pSTAT, pERK, pPI3K) under different treatment conditions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/19", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "Includes comparative data against Mogamulizumab (MAVORIC trial) and visual evidence of skin improvement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/20", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/21", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a circular process diagram to show the feedback loop of immune cell activation and hair follicle damage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/22", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "traction", "function": "show_traction", "notes": "Includes photographic evidence of hair regrowth over 21 days and a bar chart showing fold reduction of NKG2D marker.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/23", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide compares two different drugs (baricitinib and deuruxolitinib) using their respective clinical trial data (BRAVE AA1 and THRIVE AA1).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/24", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "pain_points", "function": "frame_problem", "notes": "Includes a blackbox warning text block as a competitive/safety barrier context.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/25", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-25", "loopMatches": [ { "to": 26, "from": 25, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "44fd4bbd-5f87-4521-8161-1ac784d2c26a", "evidence": "The deck presents information on the large unmet need in alopecia areata", "position": 0, "objective": "Highlight the large unmet need in alopecia areata", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a clinical trial methodology and the strategic positioning of the drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/26", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-26", "loopMatches": [ { "to": 26, "from": 25, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "44fd4bbd-5f87-4521-8161-1ac784d2c26a", "evidence": "The deck presents information on the large unmet need in alopecia areata", "position": 0, "objective": "Highlight the large unmet need in alopecia areata", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/27", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses a contrast-based framing (750k patients vs 0 drugs) to establish market opportunity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/28", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a four-column structure to explain the biological rationale, molecular nature, mechanism of action, and clinical status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/29", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a heatmap showing gene expression profiles under different cytokine conditions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/30", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a circular process diagram to show the mechanism of action and a bar chart to show efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/31", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "why_now", "function": "size_opportunity", "notes": "The slide uses a process-like flow to highlight the specific mechanism of action (IL-15/IL-21) compared to other approaches.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/32", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-32", "loopMatches": [ { "to": 33, "from": 32, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "9dba4129-78e2-4c77-b498-89d21b1c341b", "evidence": "The deck presents information on the potential for EQ102 in celiac disease", "position": 1, "objective": "Highlight the potential for EQ102 to be a differentiated asset in celiac disease", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide outlines a sequential clinical trial process.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/33", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-33", "loopMatches": [ { "to": 33, "from": 32, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "9dba4129-78e2-4c77-b498-89d21b1c341b", "evidence": "The deck presents information on the potential for EQ102 in celiac disease", "position": 1, "objective": "Highlight the potential for EQ102 to be a differentiated asset in celiac disease", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/34", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "team_bio", "function": "other", "notes": "The slide combines individual team member bios with a collective logo grid of past affiliations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/35", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 36, "from": 35, "beatId": "7e9cc88f-1575-42b8-8db4-7aeb85971bd0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The deck presents information on Equillium's leadership team", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix", "function": "other", "notes": "The slide uses a Gantt-style timeline to show the duration of IP protection for various therapeutic assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/36", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 36, "from": 35, "beatId": "7e9cc88f-1575-42b8-8db4-7aeb85971bd0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The deck presents information on Equillium's leadership team", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "appendix_data", "function": "summarize", "notes": "Includes a disclaimer regarding the Form 10-Q and a footnote about debt facility prepayment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/37", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a table-like structure to present clinical trial milestones and financial runway.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/38", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-89b3-76e0-854f-751e522d63c5", "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/39", "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5", "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "The slide uses a high-quality stock photo to evoke an emotional connection to the company's mission.", "imagePath": "https://imgproxy.kitesheet.com/2vTPp8B8tCN7KKZCmnN-rFoUWHe6Gc-YHQaYuIIJ31Q/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kYTg2MDhiZGY0YWQzODU2OTlkMTM0MGRiN2RjZTE4NS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/1", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/8L89RdwWTT8XTJI0iMK-4Qi7gVsiCBaZhIxnwqSxXrg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kYTg2MDhiZGY0YWQzODU2OTlkMTM0MGRiN2RjZTE4NS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/MIL8mscqJpohAqYjUUR4MWlgauIJCxlwfbXFovJns-U/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kYTg2MDhiZGY0YWQzODU2OTlkMTM0MGRiN2RjZTE4NS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/TRPEo4Un2XSyPAWNI-oNwqEazzMVBSUmrqdCZStKM-g/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kYTg2MDhiZGY0YWQzODU2OTlkMTM0MGRiN2RjZTE4NS9wMDAxLnBuZw" }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/2", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "mission", "function": "inspire_vision", "notes": "The slide uses a hub-and-spoke diagram to connect the company name to three core pillars: leadership, portfolio, and financials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/3", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "team_bio", "function": "other", "notes": "SAB stands for Scientific Advisory Board.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/4", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The table uses a heatmap-style color coding where red indicates existing targeted therapy markets and teal indicates blue ocean opportunities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/5", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for the company's therapeutic approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/6", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "0d5585a9-7b54-4f2c-9a73-c08e413c7e8e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Erasca's pipeline and potential solutions for addressing the unmet needs in cancer treatment.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization for clinical trial stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/7", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "0d5585a9-7b54-4f2c-9a73-c08e413c7e8e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Erasca's pipeline and potential solutions for addressing the unmet needs in cancer treatment.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a biological process diagram to map drug assets to specific protein targets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/8", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "0d5585a9-7b54-4f2c-9a73-c08e413c7e8e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Erasca's pipeline and potential solutions for addressing the unmet needs in cancer treatment.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a matrix structure to map indications to benchmarks, specific drug regimens, and trial names, with a footer detailing active clinical trial collaboration and supply agreements (CTCSAs).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/9", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "0d5585a9-7b54-4f2c-9a73-c08e413c7e8e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Erasca's pipeline and potential solutions for addressing the unmet needs in cancer treatment.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The chart uses a stacked bar approach to represent US and European patient counts per clinical program.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/10", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "0d5585a9-7b54-4f2c-9a73-c08e413c7e8e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Erasca's pipeline and potential solutions for addressing the unmet needs in cancer treatment.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide combines a biological pathway diagram (left) with a quantitative market sizing table (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/11", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "0d5585a9-7b54-4f2c-9a73-c08e413c7e8e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Erasca's pipeline and potential solutions for addressing the unmet needs in cancer treatment.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "solution", "function": "present_solution", "notes": "The kinome tree visualization (KINOMEscan) is a standard industry tool for demonstrating kinase selectivity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/12", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "0d5585a9-7b54-4f2c-9a73-c08e413c7e8e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Erasca's pipeline and potential solutions for addressing the unmet needs in cancer treatment.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide combines a biological pathway diagram (mechanism of action) with a clinical trial summary table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/13", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "0d5585a9-7b54-4f2c-9a73-c08e413c7e8e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Erasca's pipeline and potential solutions for addressing the unmet needs in cancer treatment.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 20, "from": 13, "beatId": "f286216e-8f02-4c67-ba26-139ada264780", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document provides evidence and proof of Erasca's pipeline and its potential effectiveness.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "Includes two waterfall plots comparing patient responses; source cited as Novartis materials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/14", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "0d5585a9-7b54-4f2c-9a73-c08e413c7e8e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Erasca's pipeline and potential solutions for addressing the unmet needs in cancer treatment.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 20, "from": 13, "beatId": "f286216e-8f02-4c67-ba26-139ada264780", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document provides evidence and proof of Erasca's pipeline and its potential effectiveness.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-8a55-750a-8008-603750933d71", "docSlug": "da8608bdf4ad385699d1340db7dce185", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/15", "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71", "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-15", "loopMatches": [ { "to": 20, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "1dd29138-5e83-440f-a4ea-0cd29a31a0c3", "evidence": "The document highlights the limitations of current treatments and the potential benefits of Erasca's pipeline.", "position": 0, "objective": "What is the cost of not addressing the unmet needs in cancer treatment?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 15, "from": 15, "beatId": "083e76e7-2308-4452-b206-48463d7bb6e5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the current standard of care for NRASm metastatic melanoma and its limitations.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 20, "from": 15, "beatId": "0ba8dc28-f394-4539-9ceb-99555f1271c2", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document highlights the unmet needs and limitations of current treatments for NRASm metastatic melanoma.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" }, { "to": 20, "from": 13, "beatId": "f286216e-8f02-4c67-ba26-139ada264780", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document provides evidence and proof of Erasca's pipeline and its potential effectiveness.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }